Has Lynette Sholl, MD received payments from drug or device companies?

Yes. Drug and device makers reported $6,378 in general payments to Lynette Sholl, MD across 12 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Lynette Sholl, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Lynette Sholl, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Lynette Sholl, MD

Anatomic Pathology · Boston, MANPI 1417015017

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $5,460 of the $6,378 with a category attached, or 85.6%. 5 manufacturers reported payments, led by AstraZeneca at 54.2% of the total. Reporting peaked in 2022 at $3,025 and has fallen 50.4% since, to $1,500 in 2025.

$6,378in general payments, 2019–2025

Across 12 payments — averaging $531.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AstraZeneca$3K
Eli Lilly$1K
EMD Serono, Inc.$1K
E.r. Squibb & Sons, L.L.C.$302
Genentech USA, Inc.$156

$2,475in research payments, 2019–2025

Across 5 payments — averaging $494.96 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

F. Hoffmann-la Roche AG$2K

What the payments were for

Consulting fees$5,46086%
Travel & lodging$3295%
Food & beverage$5899%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AstraZeneca	5	$3,458
Eli Lilly	1	$1,400
EMD Serono, Inc.	2	$1,062
E.r. Squibb & Sons, L.L.C.	2	$302
Genentech USA, Inc.	2	$156

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

TAGRISSO$133

How this compares

$6,378 in reported general payments places this provider in the 80th percentile of 119 anatomic pathology providers in Massachusetts.

See all anatomic pathology providers in Massachusetts →

Medicare billing

Part B allowed, 2024

$82,440

Medicare patients

501

Services billed

1,570

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other anatomic pathology in Boston

Mari Mino KenudsonBoston$143K
Hatice GurBoston$112K
Keith LigonBoston$88K
Sarah HillBoston$54K
Robert ColvinBoston$46K
Lauren Ritterhouse CasariegoBoston$39K
Gregory LauwersBoston$27K
Robert PaderaBoston$22K
Frederick SchoenBoston$21K
Andrew BeckBoston$17K

See the full list for Massachusetts →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →